Skip to Main Content

Author Details

Tahmineh Romero
David Geffen School of Medicine at university of california los angeles
2019
43
13
PMIDPaper TitleJournal TitlePublished Year
35058580Significant changes in macrophage and CD8 T cell densities in primary prostate tumors 2 weeks after SBRT.Prostate Cancer Prostatic Dis2023
37639648Biochemical Recurrence Surrogacy for Clinical Outcomes After Radiotherapy for Adenocarcinoma of the Prostate.J Clin Oncol2023
35411827Cell saver blood transfusions may be associated with a decrease in inflammation and improved outcome measures in pediatric cardiac surgery patients.Perfusion2023
37023987Safety and Efficacy Results From iSABR, a Phase 1 Study of Stereotactic ABlative Radiotherapy in Combination With Durvalumab for Early-Stage Medically Inoperable Non-Small Cell Lung Cancer.Int J Radiat Oncol Biol Phys2023
37152892Assessment of Differences in Academic Rank and Compensation by Gender and Race/Ethnicity Among Academic Radiation Oncologists in the United States.Adv Radiat Oncol2023
37244972Protein biomarkers of disease progression in patients with systemic sclerosis associated interstitial lung disease.Sci Rep2023
36398422Outcomes in preterm infants who received a lipid emulsion with fish oil: An observational study.JPEN J Parenter Enteral Nutr2023
36938850Among men, androgens are associated with a decrease in Alzheimer's disease risk.Alzheimers Dement2023
36179990External Beam Radiation Therapy With or Without Brachytherapy Boost in Men With Very-High-Risk Prostate Cancer: A Large Multicenter International Consortium Analysis.Int J Radiat Oncol Biol Phys2023
36269935Sequencing of Androgen-Deprivation Therapy of Short Duration With Radiotherapy for Nonmetastatic Prostate Cancer (SANDSTORM): A Pooled Analysis of 12 Randomized Trials.J Clin Oncol2023
34389938Overwhelmed: a Dementia Caregiver Vital Sign.J Gen Intern Med2022
35469702High-dose Radiotherapy or Androgen Deprivation Therapy (HEAT) as Treatment Intensification for Localized Prostate Cancer: An Individual Patient-data Network Meta-analysis from the MARCAP Consortium.Eur Urol2022
35420651Association Between Social Determinants of Health and Retinopathy of Prematurity Outcomes.JAMA Ophthalmol2022
35858662Admission Source Is Associated With the Risk of Rapid Response Team Activation in a Children's Hospital.Acad Pediatr2022
35934601Local Failure Events in Prostate Cancer Treated with Radiotherapy: A Pooled Analysis of 18 Randomized Trials from the Meta-analysis of Randomized Trials in Cancer of the Prostate Consortium (LEVIATHAN).Eur Urol2022
35187225A Prospective Observational Study Assessing the Impacts of Health Literacy and Psychosocial Determinants of Health on 30-day Readmission Risk.J Patient Exp2022
35051385Androgen deprivation therapy use and duration with definitive radiotherapy for localised prostate cancer: an individual patient data meta-analysis.Lancet Oncol2022
35050303Interplay Between Duration of Androgen Deprivation Therapy and External Beam Radiotherapy With or Without a Brachytherapy Boost for Optimal Treatment of High-risk Prostate Cancer: A Patient-Level Data Analysis of 3 Cohorts.JAMA Oncol2022
32451757Adenoma and Advanced Adenoma Detection Rates of Water Exchange, Endocuff, and Cap Colonoscopy: A Network Meta-Analysis with Pooled Data of Randomized Controlled Trials.Dig Dis Sci2021
33493615Stereotactic Body Radiotherapy for High-Risk Localized Carcinoma of the Prostate (SHARP) Consortium: Analysis of 344 Prospectively Treated Patients.Int J Radiat Oncol Biol Phys2021
33714024Caregiver outcomes of a dementia care program.Geriatr Nurs2021
33647253Growth Failure Prevalence in Neonates with Gastroschisis : A Statewide Cohort Study.J Pediatr2021
34902034Performance of a Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography-Derived Risk-Stratification Tool for High-risk and Very High-risk Prostate Cancer.JAMA Netw Open2021
34964855Comparison of Response to Definitive Radiotherapy for Localized Prostate Cancer in Black and White Men: A Meta-analysis.JAMA Netw Open2021
34590007Investigation of Combination Treatment With an Aromatase Inhibitor Exemestane and Carboplatin-Based Therapy for Postmenopausal Women With Advanced NSCLC.JTO Clin Res Rep2021
34585025Toxicity After Stereotactic Body Radiation Therapy for Prostate Cancer in Patients With Inflammatory Bowel Disease: A Multi-institutional Matched Case-Control Series.Adv Radiat Oncol2021
34622488Sessile serrated adenoma/polyp detection rate of water exchange, Endocuff, and cap colonoscopy: A network meta-analysis.J Gastroenterol Hepatol2021
33940207Adverse Childhood Experiences and Association With Pediatric Asthma Severity in the 2016-2017 National Survey of Children's Health.Acad Pediatr2021
33985797Patterns of Clinical Progression in Radiorecurrent High-risk Prostate Cancer.Eur Urol2021
34196715Comparison of Multimodal Therapies and Outcomes Among Patients With High-Risk Prostate Cancer With Adverse Clinicopathologic Features.JAMA Netw Open2021
33258124Validation of a Brief Multi-Dimensional Assessment of Dementia Severity.J Am Geriatr Soc2021
33479269Tissue-specific endothelial cell heterogeneity contributes to unequal inflammatory responses.Sci Rep2021
32647353The intraprostatic immune environment after stereotactic body radiotherapy is dominated by myeloid cells.Prostate Cancer Prostatic Dis2021
32168528Growth from Birth to 30 months for Infants Born with Congenital Gastrointestinal Anomalies and Disorders.Am J Perinatol2021
31346616Early Clinical Infancy Outcomes for Microcephaly and/or Small for Gestational Age Zika-Exposed Infants.Clin Infect Dis2020
31674036Disease characteristics of diffuse large B-cell lymphoma predicting relapse and survival after autologous stem cell transplantation: A single institution experience.Hematol Oncol2020
32461072Transcriptomic Heterogeneity of Gleason Grade Group 5 Prostate Cancer.Eur Urol2020
32229199Durable Survival Outcomes in Primary and Secondary Central Nervous System Lymphoma After High-dose Chemotherapy and Autologous Stem Cell Transplantation Using a Thiotepa, Busulfan, and Cyclophosphamide Conditioning Regimen.Clin Lymphoma Myeloma Leuk2020
32197352Tumor Size Matters-Understanding Concomitant Tumor Immunity in the Context of Hypofractionated Radiotherapy with Immunotherapy.Cancers (Basel)2020
29672178Obese- and allergic-related asthma phenotypes among children across the United States.J Asthma2019
30675898The Effect of a Comprehensive Dementia Care Management Program on End-of-Life Care.J Am Geriatr Soc2019
31365112Association Between Neonatal Neuroimaging and Clinical Outcomes in Zika-Exposed Infants From Rio de Janeiro, Brazil.JAMA Netw Open2019
31355423Patient and Caregiver Benefit From a Comprehensive Dementia Care Program: 1-Year Results From the UCLA Alzheimer's and Dementia Care Program.J Am Geriatr Soc2019
  • 1 - 43 of 43

Recommended Authors

Mayo Clinic
Career Start Year 2018
Number of shared co-authors 0
Weill Cornell Medical College
Career Start Year 2017
Number of shared co-authors 6
Princess Margaret Hospital
Career Start Year 2017
Number of shared co-authors 2
Mayo Clinic
Career Start Year 2017
Number of shared co-authors 0
Memorial Sloan Kettering Cancer Center
Career Start Year 2015
Number of shared co-authors 1
Mayo Clinic
Career Start Year 2013
Number of shared co-authors 1
University of Texas Health San Antonio
Career Start Year 2013
Number of shared co-authors 0
Princess Margaret Cancer Centre, University Health Network
Career Start Year 2013
Number of shared co-authors 10
Center for Research on Health Care, University of Pittsburgh
Career Start Year 2012
Number of shared co-authors 0
School of Medicine Case Western Reserve University Cleveland OH USA.
Career Start Year 2011
Number of shared co-authors 20
Brigham and Women's Hospital
Career Start Year 2010
Number of shared co-authors 5
Department of Health Services, Brown University School of Public Health
Career Start Year 2010
Number of shared co-authors 1
Colleges of Medicine, University of Florida
Career Start Year 2009
Number of shared co-authors 0
University of Michigan School of Public Health ann arbor
Career Start Year 2009
Number of shared co-authors 5
Georgetown University
Career Start Year 2008
Number of shared co-authors 1
Cross Cancer Institute
Career Start Year 2006
Number of shared co-authors 2
Harvard Medical School
Career Start Year 2004
Number of shared co-authors 0
Massachusetts General Hospital
Career Start Year 2003
Number of shared co-authors 0
University of Colorado Anschutz Medical Campus
Career Start Year 2001
Number of shared co-authors 0
Case Western Reserve University
Career Start Year 2000
Number of shared co-authors 1
David Geffen School of Medicine, University of California los angeles
Career Start Year 1998
Number of shared co-authors 7
Stanford University
Career Start Year 1997
Number of shared co-authors 0
Center for Research and Analytics, American Society of Clinical Oncology
Career Start Year 1997
Number of shared co-authors 3
University Health Network
Career Start Year 1994
Number of shared co-authors 0
Virginia Tech
Career Start Year 1994
Number of shared co-authors 8
Boston Children's Hospital and Dana-Farber Cancer Institute, Harvard Medical School
Career Start Year 1994
Number of shared co-authors 17
Icahn School of Medicine at Mount Sinai
Career Start Year 1992
Number of shared co-authors 0
Princess Margaret Cancer Centre
Career Start Year 1991
Number of shared co-authors 5
Harvard Medical School
Career Start Year 1988
Number of shared co-authors 6

Collaborators

University of California los angeles
Co-authored papers 17
University of California los angeles
Co-authored papers 16
University of California, Veteran Affairs Greater Los Angeles Healthcare System
Co-authored papers 16
David Geffen School of Medicine, University of California los angeles
Co-authored papers 14
David Geffen School of Medicine at university of california los angeles
Co-authored papers 13
University Hospitals Seidman Cancer Center, Case Western Reserve University
Co-authored papers 12
David Geffen School of Medicine at University of California los angeles
Co-authored papers 10
University of Washington
Co-authored papers 9
UCSF Medical Center-Mount Zion
Co-authored papers 9
Mayo Clinic
Co-authored papers 9
University of Michigan ann arbor
Co-authored papers 7
University of California los angeles
Co-authored papers 7
university of california los angeles Medical Center
Co-authored papers 6
University of California Los Angeles
Co-authored papers 6
Mayo Clinic
Co-authored papers 6
University of Maryland School of Medicine
Co-authored papers 6
University Hospitals Seidman Cancer Centre, Cleveland Medical Centre
Co-authored papers 6
Cleveland Clinic
Co-authored papers 5
Oslo University Hospital
Co-authored papers 5
Mayo Clinic
Co-authored papers 5
Taussig Cancer Institute, Cleveland Clinic
Co-authored papers 5
Ascension Providence Hospital
Co-authored papers 5
Johns Hopkins University
Co-authored papers 5
Fox Chase Cancer Center
Co-authored papers 5
University of California los angeles
Co-authored papers 5
Oslo University Hospital
Co-authored papers 5
Hospital Universitari Vall d'Hebron
Co-authored papers 5
Cleveland Clinic
Co-authored papers 5
University of California los angeles
Co-authored papers 5
Princess Margaret Cancer Centre, University of Toronto
Co-authored papers 5